中文名：Osilodrostat (LCI699)
英文名：Osilodrostat (LCI699)
纯度：Moligand™，≥99%
货号：O413758
Cas号：928134-65-0
存储温度：-20°C储存
运输条件：超低温运输
产品介绍：
Information
Osilodrostat (LCI699) LCI699(Osilodrostat) is a potent inhibitor of 11β-hydroxylase (CYP11B) , an enzyme catalyzing the final step of cortisol synthesis.
Targets
11β-hydroxylase 2.5 nM
In vitro
LCI699 also inhibits aldosterone synthase (CYP11B2) other than CYP11B1.
In vivo
LCI699 is a potent inhibitor of 11β-hydroxylase (CYP11B1), the enzyme that catalyzes the final step of cortisol synthesis, and has a half-life of ∼4 hours. It decreases blood pressure (BP) in patients with essential hypertension and primary aldosteronism. Treatment with LCI699 is well tolerated, it is demonstrated efficacy with a satisfactory safety and tolerability profile in the proof-of-concept study in Cushing\'s disease. The administration of LCI699, up to 1.0 mg BID, effectively and safely inhibits aldosterone synthase in patients with primary aldosteronism.
查看阿拉丁官网此产品相关对应页面：https://www.aladdin-e.com/zh_cn/O413758.html
关键字： 奥西洛司他 (LCI699);(R)-4-(6,7-Dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluorobenzonitrile ; GTPL8310 ; 5YL4IQ1078
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代码：688179），专注于科研试剂的研发、生产和销售，已陆续建立多个工厂和研发中心。作为领军企业，阿拉丁始终坚持质量第一，连续13年被评为“最受欢迎试剂品牌”。
阿拉丁目前常备库存试剂产品品种超过7万种，SKU总数超过46万，产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域，是国内少数化学试剂到生物试剂全面发展的国产试剂品牌，产品同步发布在我们国内外电商平台。